Lars Gullestad

27.6k total citations · 3 hit papers
462 papers, 17.3k citations indexed

About

Lars Gullestad is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Lars Gullestad has authored 462 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 265 papers in Cardiology and Cardiovascular Medicine, 169 papers in Surgery and 84 papers in Molecular Biology. Recurrent topics in Lars Gullestad's work include Transplantation: Methods and Outcomes (104 papers), Cardiovascular Function and Risk Factors (63 papers) and Heart Failure Treatment and Management (57 papers). Lars Gullestad is often cited by papers focused on Transplantation: Methods and Outcomes (104 papers), Cardiovascular Function and Risk Factors (63 papers) and Heart Failure Treatment and Management (57 papers). Lars Gullestad collaborates with scholars based in Norway, Sweden and Denmark. Lars Gullestad's co-authors include Thor Ueland, Pål Aukrust, Arne Yndestad, Stig S. Frøland, Pål Aukrust, Jan Kristian Damås, John Kjekshus, Svein Simonsen, Erik Øie and Bente Halvorsen and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Lars Gullestad

449 papers receiving 17.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EUR Observational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

2013 588 citations Aldo P. Maggioni, Ulf Dahlström et al. European Journal of Heart Failure profile →
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial

2016 288 citations Ola Kleveland, Gabor Kunszt et al. profile →
Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial

2016 271 citations Lars Aaberge, Knut Endresen et al. profile →

Peers

Countries citing papers authored by Lars Gullestad

Since Specialization

Citations

This map shows the geographic impact of Lars Gullestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Gullestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Gullestad more than expected).

Fields of papers citing papers by Lars Gullestad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Gullestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Gullestad. The network helps show where Lars Gullestad may publish in the future.

Co-authorship network of co-authors of Lars Gullestad

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Gullestad. A scholar is included among the top collaborators of Lars Gullestad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Gullestad. Lars Gullestad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Changes in 6‐min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction 2024 ·European Journal of Heart Failure ·Peder L. Myhre, Øyunn Kleiven, (unknown), Morten Grundtvig, Lars Gullestad, Stein Ørn	1
2	Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI 2024 ·International Journal of Cardiology ·Sindre Woxholt, Thor Ueland, Pål Aukrust, Anne Kristine Anstensrud, Kaspar Broch, Ingvild Maria Tøllefsen, Ingebjørg Seljeflot, Bente Halvorsen, Tuva B. Dahl, (unknown), Geir Øystein Andersen, Lars Gullestad, Rune Wiseth, Jan Kristian Damås, Ola Kleveland	1
3	Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension 2024 ·Heart ·(unknown), Klaus Murbræch, (unknown), Rune Andersen, Narve Moe, S Birkeland, Morten Svalebjørg, Per Snorre Lingaas, (unknown), Lars Gullestad, John‐Peder Escobar Kvitting, Kaspar Broch, (unknown)	1
4	Development of a Tool to Predict the Risk of Incident Heart Failure in a General Population: The HUNT for HF Risk Score 2023 ·ESC Heart Failure ·Anne Pernille Ofstad, Cathrine Brunborg, Odd Erik Johansen, Bjørn Mørkedal, Morten Wang Fagerland, Lars Erik Laugsand, Lars Gullestad, Håvard Dalen	3
5	Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Comparison of changes in hemodynamics and functional capacity 2023 ·Pulmonary Circulation ·(unknown), Rune Andersen, S Birkeland, Morten Svalebjørg, Per Snorre Lingaas, (unknown), Lars Gullestad, John‐Peder Escobar Kvitting, Kaspar Broch, (unknown)	7
6	Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial 2020 ·European Heart Journal - Cardiovascular Pharmacotherapy ·(unknown), Nils Tore Vethe, Kari Peersen, Morten Wang Fagerland, (unknown), (unknown), Morten Lindberg, Erik Gjertsen, Lars Gullestad, Joep Perk, Toril Dammen, Stein Bergan, Einar Husebye, Jan Erik Otterstad, John Munkhaugen	19
7	Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic Stenosis 2019 ·The Journal of Immunology ·(unknown), Thor Ueland, (unknown), Annika E. Michelsen, Judith Krey Ludviksen, (unknown), Kjell I. Pettersen, Svend Aakhus, (unknown), Ida G. Lunde, Michael Kirschfink, Per H. Nilsson, Tom Eirik Mollnes, Lars Gullestad, Pål Aukrust, Arne Yndestad, Mieke C. Louwe	8
8	High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes 2018 ·Atherosclerosis ·Martin Heier, Anne Pernille Ofstad, Mark S. Borja, Cathrine Brunborg, Knut Endresen, Lars Gullestad, Kåre I. Birkeland, Odd Erik Johansen, Michael N. Oda	6
9	Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction 2018 ·International Journal of Cardiology ·Ola Kleveland, Thor Ueland, Gabor Kunszt, (unknown), Arne Yndestad, Kaspar Broch, Espen Holte, Liv Ryan, Brage H. Amundsen, Bjørn Bendz, Svend Aakhus, Terje Espevik, Bente Halvorsen, Tom Eirik Mollnes, Rune Wiseth, Lars Gullestad, Pål Aukrust, Jan Kristian Damås	27
10	Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipients 2017 ·Open Heart ·(unknown), Thor Ueland, Pål Aukrust, Annika E. Michelsen, Elisabeth Bjørkelund, Lars Gullestad, Kari Nytrøen	16
11	Determinants and Outcome of Decision Making Among Patients with Severe Aortic Stenosis. 2017 ·PubMed ·(unknown), (unknown), Cathrine Brunborg, Svend Aakhus, Arnt E. Fiane, Kjell I. Pettersen, Lars Gullestad	1
12	CCL21 is Associated with Fatal Outcomes in Chronic Heart Failure: Data from CORONA and GISSI-HF Trials 2013 ·European Journal of Heart Failure ·Thor Ueland, Ståle H. Nymo, Roberto Latini, John J.V. McMurray, John Kjekshus, Arne Yndestad, Alessandro Fucili, Aurelia Grosu, Serge Masson, Aldo P. Maggioni, Lars Gullestad, Pål Aukrust	15
13	Soluble ST2 is Associated with Adverse Outcome in Patients with Heart Failure of Ischaemic Aetiology 2012 ·European Journal of Heart Failure ·Kaspar Broch, Thor Ueland, Ståle H. Nymo, John Kjekshus, Johannes Hulthe, Pieter Muntendam, John J.V. McMurray, John Wikstrand, John G.F. Cleland, Pål Aukrust, Lars Gullestad	106
14	Pentraxin-3 in Chronic Heart Failure: The CORONA and GISSI-HF Trials 2012 ·European Journal of Heart Failure ·Roberto Latini, Lars Gullestad, Serge Masson, Ståle H. Nymo, Thor Ueland, Ivan Cuccovillo, Mari Vårdal, Barbara Bottazzi, Alberto Mantovani, Donata Lucci, (unknown), Yukio SUDO, John Wikstrand, Gianni Tognoni, Pål Aukrust, Luigi Tavazzi	80
15	High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis 2012 ·Scandinavian Cardiovascular Journal ·Ole Geir Solberg, Thor Ueland, Ragnhild Wergeland, Christen P. Dahl, Svend Aakhus, Pål Aukrust, Lars Gullestad	23
16	Abstract 8551: Left Atrial Strain by Speckle Tracking Echocardiography In Patients with Heart Failure - An Independent and Incremental Predictor of Cardiac Death or Need of Heart Transplantation 2011 ·Circulation ·Thomas Helle-Valle, Anders Opdahl, Kaspar Broch, (unknown), (unknown), Otto A. Smiseth, Lars Gullestad	2
17	EUR Observational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot) 2010 ·European Journal of Heart Failure ·Aldo P. Maggioni, Ulf Dahlström, Gerasimos Filippatos, Ovidiu Chioncel, Marisa Crespo Leiro, Jarosław Dróżdż, Friedrich Fruhwald, Lars Gullestad, Damien Logeart, Marco Metra, John Parissis, Hans Persson, Piotr Ponikowski, Mathias Rauchhaus, Adriaan A. Voors, Olav Wendelboe Nielsen, Faı̈ez Zannad, Luigi Tavazzi	295
18	Intra-Aortic Balloon Counterpulsation as a Bridge to Heart Transplantation does not Impair Long-Term Survival 2009 ·European Journal of Heart Failure ·Ola Gjesdal, (unknown), Satish Arora, Torbjørn Leivestad, (unknown), Lars Gullestad, Lars Aaberge, Harald Brunvand, Thor Edvardsen, Odd Geiran, Svein Simonsen	45
19	Increased Expression of LIGHT/TNFSF14 and its Receptors in Experimental and Clinical Heart Failure 2008 ·European Journal of Heart Failure ·Christen P. Dahl, Lars Gullestad, Børre Fevang, Are Martin Holm, Linn Landrø, Leif Erik Vinge, Arnt E. Fiane, Wiggo J. Sandberg, Kari Otterdal, Stig S. Frøland, Jan Kristian Damås, Bente Halvorsen, Pål Aukrust, Erik Øie, Arne Yndestad	28
20	Importance of decreased heart rate in predicting transplant coronary artery disease 1997 ·Clinical Transplantation ·Lars Gullestad, Heather J. Ross, (unknown), Khánh Hoàng, Sharon Hunt, E. B. Stinson, Hannah A. Valantine	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact